Cervical preparation for second-trimester surgical abortion prior to 20 weeks of gestation

Contraception

Volumn 76, Issue 6, 2007, Pages 486-495

[No Author Info available]

Author keywords

Cervical dilation; Dilapan; Dilation and Evacuation; Dilator; Lamicel; Laminaria; Misoprostol

Indexed keywords

DILAPAN; LAMICEL; MISOPROSTOL; PLACEBO; PROSTAGLANDIN DERIVATIVE;

ARTICLE; BACTERIUM CONTAMINATION; CESAREAN SECTION; CLINICAL DECISION MAKING; CLINICAL TRIAL; CLOSTRIDIUM PERFRINGENS; DRUG EFFICACY; DRUG MECHANISM; ESCHERICHIA COLI; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HYDROGEL; INDUCED ABORTION; INTERMETHOD COMPARISON; LAMINARIA; LAMINARIA DIGITATA; LAMINARIA JAPONICA; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREOPERATIVE CARE; RISK REDUCTION; SECOND TRIMESTER ABORTION; SEPSIS; SPONTANEOUS ABORTION; TREATMENT PLANNING; UNITED STATES; UTERINE CERVIX DILATATION; UTERINE CERVIX DILATATOR; UTERINE CERVIX INCOMPETENCE; UTERUS DISEASE;

ABORTION, INDUCED; CERVIX UTERI; FEMALE; HUMANS; LABOR STAGE, FIRST; LAMINARIA; MAGNESIUM SULFATE; MISOPROSTOL; POLYMERS; POLYVINYL ALCOHOL; PREGNANCY; PREGNANCY TRIMESTER, SECOND; VACUUM CURETTAGE;

EID: 36549071665     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.09.004     Document Type: Article

References (84)

1. Finer L.B., and Henshaw S.K. Estimates of U.S. Abortion Incidence, 2001-2003. Alan Guttmacher Institute (2006). http://www.guttmacher.org/pubs/2006/08/03/ab_incidence.pdf [Accessed 5/17/07] [Evidence Grade: II-3]
2. Strauss L.T., Gamble S.B., Parker W.Y., Cook D.A., Zane S.B., Hamdan S., et al. Abortion surveillance - United States, 2003. Morb Mortal Wkly Rep Surveill Summ 55 (2006) 1-32 [Evidence Grade: II-3]
3. Haskell W., Easterline T., and Lichtenberg E.S. Surgical abortion after the first trimester. In: Paul M., Lichtenberg E.S., Borgatta L., Grimes D.A., and Stubblefield P.G. (Eds). A clinician's guide to medical and surgical abortion (1999), Churchill Livingstone, London 123-138 [Evidence Grade: III]
4. Altman A.M., Stubblefield P.G., Schlam J.F., Loberfeld R., and Osathanondh R. Midtrimester abortion with Laminaria and vacuum evacuation on a teaching service. J Reprod Med 30 (1985) 601-606 [Evidence Grade: II-3]
5. Hern W.M. Serial multiple laminaria and adjunctive urea in late outpatient dilatation and evacuation abortion. Obstet Gynecol 63 (1984) 543-549 [Evidence Grade: II-3]
6. Jacot F.R., Poulin C., Bilodeau A.P., Morin M., Moreau S., Gendron F., et al. A five-year experience with second-trimester induced abortions: no increase in complication rate as compared to the first trimester. Am J Obstet Gynecol 168 (1993) 633-637 [Evidence Grade: II-2]
7. Peterson W.F., Berry F.N., Grace M.R., and Gulbranson C.L. Second-trimester abortion by dilatation and evacuation: an analysis of 11,747 cases. Obstet Gynecol 62 (1983) 185-190 [Evidence Grade: II-3]
8. WHO Task Force on Sequelae of Abortion. Gestation, birthweight, and spontaneous abortion in pregnancy after induced abortion. Lancet (1979) 1143-1145 [Evidence Grade: II-3]
9. Hogue C.J., Cates Jr. W., and Tietze C. The effects of induced abortion on subsequent reproduction. Epidemiol Rev 4 (1982) 66-94 [Evidence Grade: II-2]
10. Munsick R.A., and Fineberg N.S. Cervical dilation from multiple laminaria tents used for abortion. Obstet Gynecol 87 (1996) 726-729 [Evidence Grade: II-2]
11. Stubblefield P.G. Current technology for abortion. Curr Probl Obstet Gynecol 2 (1978) 3-44 [Evidence Grade: III-2]
12. Eaton C.J., Cohn F., and Bollinger C.C. Laminaria tent as a cervical dilator prior to aspiration-type therapeutic abortion. Obstet Gynecol 39 (1972) 535-537 [Evidence Grade: II-3]
13. Newton B.W. Laminaria tent: relic of the past or modern medical device?. Am J Obstet Gynecol 113 (1972) 442-448 [Evidence Grade: II-3]
14. Krammer J., and O'Brien W.F. Mechanical methods of cervical ripening. Clin Obstet Gynecol 38 (1995) 280-286 [Evidence Grade: III]
15. Ye B.L., Yamamoto K., and Tyson J.E. Functional and biochemical aspects of laminaria use in first-trimester pregnancy termination. Am J Obstet Gynecol 142 (1982) 36-39 [Evidence Grade: I]
16. Wheeler R.G., and Schneider K. Properties and safety of cervical dilators. Am J Obstet Gynecol 146 (1983) 597-601 [Evidence Grade: II-3]
17. Manabe Y., Mori T., and Yoshida Y. Decidual morphology and F prostaglandin in amniotic fluid in stretch-induced abortion. Obstet Gynecol 64 (1984) 661-665 [Evidence Grade: III]
18. Darney P.D. Preparation of the cervix: hydrophilic and prostaglandin dilators. Clin Obstet Gynecol 13 (1986) 43-51 [Evidence Grade: III]
19. MedGyn Products Inc. Package labeling: laminaria (2007) Lombard (Ill)
20. Bryman I., Granberg S., and Norstrom A. Reduced incidence of postoperative endometritis by the use of laminaria tents in connection with first trimester abortion. Acta Obstet Gynecol Scand 67 (1988) 323-325 [Evidence Grade: I]
21. Jonasson A., Larsson B., Bygdeman S., and Forsum U. The influence of cervical dilatation by laminaria tent and with Hegar dilators on the intrauterine microflora and the rate of postabortal pelvic inflammatory disease. Acta Obstet Gynecol Scand 68 (1989) 405-410 [Evidence Grade: I]
22. Acharya P.S., and Gluckman S.J. Bacteremia following placement of intracervical laminaria tents. Clin Infect Dis 29 (1999) 695-697 [Evidence Grade: III]
23. Lichtenberg E.S. Complications of osmotic dilators. Obstet Gynecol Surv 59 (2004) 528-536 [Evidence Grade: III]
24. Brenner W.E., and Zuspan K. Synthetic laminaria for cervical dilatation prior to vacuum aspiration in midtrimester pregnancy. Am J Obstet Gynecol 143 (1982) 475-477 [Evidence Grade: II-3]
25. Medtronic. Package labeling: lamicel osmotic cervical dilator (2007) Mystic (Conn)
26. Nicolaides K.H., Welch C.C., MacPherson M.B., Johnson I.R., and Filshie G.M. Lamicel: a new technique for cervical dilatation before first trimester abortion. Br J Obstet Gynaecol 90 (1983) 475-479 [Evidence Grade: I]
27. Bokstrom H., and Wiqvist N. Prostaglandin release from human cervical tissue in the first trimester of pregnancy after preoperative dilatation with hygroscopic tents. Prostaglandins 50 (1995) 179-188 [Evidence Grade: II-1]
28. Norstrom A., Bryman I., and Hansson H.A. Cervical dilatation by Lamicel before first trimester abortion: a clinical and experimental study. Br J Obstet Gynaecol 95 (1988) 372-376 [Evidence Grade: II-1]
29. Nicolaides K.H., Welch C.C., Koullapis E.N., and Filshie G.M. Cervical dilatation by Lamicel - studies on the mechanism of action. Br J Obstet Gynaecol 90 (1983) 1060-1064 [Evidence Grade: II-3]
30. Radestad A., and Christensen N.J. Magnesium sulphate and cervical ripening (a biomechanical double-blind, randomized comparison between a synthetic polyvinyl sponge with and without magnesium sulphate). Contraception 39 (1989) 253-263 [Evidence Grade: I]
31. Tan S.L., Cheng H., Ho K.K., Mitra R., Hii J., and Yeo K.C. Lamicel is more effective in preparing the cervix for midtrimester termination of pregnancy than Laminaria japonicum. Aust N Z J Obstet Gynaecol 28 (1988) 49-52 [Evidence Grade: I]
32. Grimes D.A., Ray I.G., and Middleton C.J. Lamicel versus laminaria for cervical dilation before early second-trimester abortion: a randomized clinical trial. Obstet Gynecol 69 (1987) 887-890 [Evidence Grade: I]
33. Wells E.C., and Hulka J.F. Cervical dilation: a comparison of Lamicel and Dilapan. Am J Obstet Gynecol 161 (1989) 1124-1126 [Evidence Grade: I]
34. Gupta J.K., and Johnson N. Should we use prostaglandins, tents or progesterone antagonists for cervical ripening before first trimester abortion?. Contraception 46 (1992) 489-497 [Evidence Grade: II-1]
35. Gel-Med International. Package labeling: Dilapan-STM hygroscopic cervical dilator. http://www.gelmed.cz/instructions.html [Accessed 8/22/07]
36. Chvapil M., Droegemueller W., Meyer T., Macsalka R., Stoy V., and Suciu T. New synthetic laminaria. Obstet Gynecol 60 (1982) 729-733 [Evidence Grade: II-1]
37. Hern W.M. Cervical treatment with Dilapan prior to second trimester dilation and evacuation abortion: a pilot study of 64 patients. Am J Gynecol Health 7 (1993) 23-26 [Evidence Grade: II-3]
38. Hern W.M. Laminaria versus Dilapan osmotic cervical dilators for outpatient dilation and evacuation abortion: randomized cohort comparison of 1001 patients. Am J Obstet Gynecol 171 (1994) 1324-1328 [Evidence Grade: I]
39. Borgatta L., and Barad D. Prolonged retention of laminaria fragments: an unusual complication of laminaria usage. Obstet Gynecol 78 (1991) 988-990 [Evidence Grade: III]
40. Schulz K.F., Grimes D.A., and Cates Jr. W. Measures to prevent cervical injury during suction curettage abortion. Lancet 1 (1983) 1182-1185 [Evidence Grade: II-2]
41. Lauersen N.H., Den T., Iliescu C., Wilson K.H., and Graves Z.R. Cervical priming prior to dilatation and evacuation: a comparison of methods. Am J Obstet Gynecol 144 (1982) 890-894 [Evidence Grade: II-1]
42. Nguyen M.T., and Hoffman D.R. Anaphylaxis to laminaria. J Allergy Clin Immunol 95 1 Pt 1 (1995) 138-139 [Evidence Grade: III]
43. Chanda M., Mackenzie P., and Day J.H. Hypersensitivity reactions following laminaria placement. Contraception 62 (2000) 105-106 [Evidence Grade: III]
44. Kim S.H., Chang Y.H., Kim W.K., Kim Y.K., Cho S.H., Kim Y.Y., et al. Two cases of anaphylaxis after laminaria insertion. J Korean Med Sci 18 (2003) 886-888 [Evidence Grade: III]
45. Evaldson G.R., Fianu S., Jonasson A., Larsson B., Nord C.E., and Olund A.R. Does the hygroscopic property of the laminaria tent imply a risk for ascending infection in legal abortions? A microbiological study. Acta Obstet Gynecol Scand 65 (1986) 257-261 [Evidence Grade: II-2]
46. Sutkin G., Capelle S.D., Schlievert P.M., and Creinin M.D. Toxic shock syndrome after laminaria insertion. Obstet Gynecol 98 (2001) 959-961 [Evidence Grade: III]
47. Jasnosz K.M., Shakir A.M., and Perper J.A. Fatal Clostridium perfringens and Escherichia coli sepsis following urea-instillation abortion. Am J Forensic Med Pathol 14 (1993) 151-154 [Evidence Grade: II-3]
48. Schneider D., Halperin R., Langer R., Caspi E., and Bukovsky I. Abortion at 18-22 weeks by laminaria dilation and evacuation. Obstet Gynecol 88 (1996) 412-414 [Evidence Grade: II-2]
49. Kalish R.B., Chasen S.T., Rosenzweig L.B., Rashbaum W.K., and Chervenak F.A. Impact of midtrimester dilation and evacuation on subsequent pregnancy outcome. Am J Obstet Gynecol 187 (2002) 882-885 [Evidence Grade: II-3]
50. Jackson J.E., Grobman W.A., Haney E., and Casele H. Mid-trimester dilation and evacuation with laminaria does not increase the risk for severe subsequent pregnancy complications. Int J Gynaecol Obstet 96 (2007) 12-15 [Evidence Grade: II-2]
51. Preterm birth: causes, consequences, and prevention (report in brief) (2006), Institution of Medicine of the National Academies, Washington (DC). http://www.iom.edu/Object.File/Master/35/975/pretermbirth.pdf [Accessed 5/29/07] [Evidence Grade: II-3]
52. Blumenthal P.D. Prospective comparison of Dilapan and laminaria for pretreatment of the cervix in second-trimester induction abortion. Obstet Gynecol 72 (1988) 243-246 [Evidence Grade: II-1]
53. Darney P.D., and Dorward K. Cervical dilation before first-trimester elective abortion: a controlled comparison of meteneprost, laminaria, and hypan. Obstet Gynecol 70 (1987) 397-400 [Evidence Grade: I]
54. Todd C.S., Soler M., Castleman L., Rogers M.K., and Blumenthal P.D. Buccal misoprostol as cervical preparation for second trimester pregnancy termination. Contraception 65 (2002) 415-418 [Evidence Grade: II-2]
55. Goldberg A.B., Drey E.A., Whitaker A.K., Kang M.S., Meckstroth K.R., and Darney P.D. Misoprostol compared with laminaria before early second-trimester surgical abortion: a randomized trial. Obstet Gynecol 106 (2005) 234-241 [Evidence Grade: I]
56. Castleman L.D., Oanh K.T., Hyman A.G., Thuy le T., and Blumenthal P.D. Introduction of the dilation and evacuation procedure for second-trimester abortion in Vietnam using manual vacuum aspiration and buccal misoprostol. Contraception 74 (2006) 272-276 [Evidence Grade: II-3]
57. Edelman A.B., Buckmaster J.G., Goetsch M.F., Nichols M.D., and Jensen J.T. Cervical preparation using laminaria with adjunctive buccal misoprostol before second-trimester dilation and evacuation procedures: a randomized clinical trial. Am J Obstet Gynecol 194 (2006) 425-430 [Evidence Grade: I]
58. Patel A., Talmont E., Morfesis J., Pelta M., Gatter M., Momtaz M.R., et al. Adequacy and safety of buccal misoprostol for cervical preparation prior to termination of second-trimester pregnancy. Contraception 73 (2006) 420-430 [Evidence Grade: II-3]
59. Patsner B. Same-day Dilapan insertion before second-trimester dilation and evacuation for a fetal anomaly or death. J Reprod Med 41 (1996) 71-72 [Evidence Grade: III]
60. Darney P.D., Horbach N.S., and Korn A.P. Second-trimester elective abortion. Protocols for office gynecologic surgery (1996), Blackwell Science, Cambridge (Mass) 194-219 [Evidence Grade: III]
61. Gel-Med International. Package labeling: Dilapan-STM hygroscopic cervical dilator. Czech Republic. http://www.gelmed.cz/downloads/Dilapan_instruction_EN.pdf [Accessed 8/22/07]
62. Hern W.M., Zen C., Ferguson K.A., Hart V., and Haseman M.V. Outpatient abortion for fetal anomaly and fetal death from 15-34 menstrual weeks' gestation: techniques and clinical management. Obstet Gynecol 81 (1993) 301-306 [Evidence Grade: II-3]
63. Hern W.M. Laminaria, induced fetal demise and misoprostol in late abortion. Int J Gynaecol Obstet 75 (2001) 279-286 [Evidence Grade: II-3]
64. Stubblefield P.G., Altman A.M., and Goldstein S.P. Randomized trial of one versus two days of laminaria treatment prior to late midtrimester abortion by uterine evacuation: a pilot study. Am J Obstet Gynecol 143 (1982) 481-482 [Evidence Grade: I]
65. Bierer I., and Steiner V. Termination of pregnancy in the second trimester with the aid of laminaria tents. Med Gynaecol Sociol 6 (1972) 9-10 [Evidence Grade: III]
66. Hern W.M., and Oakes A.G. Multiple laminaria treatment in early midtrimester outpatient suction abortion: a preliminary report. Adv Plan Parent 12 (1977) 93-97 [Evidence Grade: III]
67. Darney P.D., Horbach N.S., and Korn A.P. Cervical dilation for intrauterine procedures. Protocols for office gynecologic surgery (1996), Blackwell Science, Cambridge (Mass) 143-157 [Evidence Grade: III]
68. Schneider D., Golan A., Langer R., Caspi E., and Bukovsky I. Outcome of continued pregnancies after first- and second-trimester cervical dilatation by laminaria tents. Obstet Gynecol 78 (1991) 1121-1123 [Evidence Grade: II-3]
69. Van Le L., and Darney P.D. Successful pregnancy outcome after cervical dilation with multiple laminaria tents in preparation for second-trimester elective abortion: a report of two cases. Am J Obstet Gynecol 156 (1987) 612-613 [Evidence Grade: III]
70. Pastuszak A.L., Schuler L., Speck-Martins C.E., Coelho K.E., Cordello S.M., Vargas F., et al. Use of misoprostol during pregnancy and Mobius' syndrome in infants. N Engl J Med 338 (1998) 1881-1885 [Evidence Grade: II-2]
71. Vargas F.R., Schuler-Faccini L., Brunoni D., Kim C., Meloni V.F., Sugayama S.M., et al. Prenatal exposure to misoprostol and vascular disruption defects: a case-control study. Am J Med Genet 95 (2000) 302-306 [Evidence Grade: II-2]
72. Schneider D., Bukovsky I., and Caspi E. Safety of midtrimester pregnancy termination by laminaria and evacuation in patients with previous cesarean section. Am J Obstet Gynecol 171 (1994) 554-557 [Evidence Grade: II-2]
73. Pridmore B.R., and Chambers D.G. Uterine perforation during surgical abortion: a review of diagnosis, management and prevention. Aust N Z J Obstet Gynaecol 39 (1999) 349-353 [Evidence Grade: II-3]
74. Wing D.A., and Gaffaney C.A. Vaginal misoprostol administration for cervical ripening and labor induction. Clin Obstet Gynecol 49 (2006) 627-641 [Evidence Grade: III]
75. Herabutya Y., Chanarachakul B., and Punyavachira P. Induction of labor with vaginal misoprostol for second trimester termination of pregnancy in the scarred uterus. Int J Gynaecol Obstet 83 (2003) 293-297 [Evidence Grade: II-2]
76. Daskalakis G.J., Mesogitis S.A., Papantoniou N.E., Moulopoulos G.G., Papapanagiotou A.A., and Antsaklis A.J. Misoprostol for second trimester pregnancy termination in women with prior caesarean section. BJOG 112 (2005) 97-99 [Evidence Grade: II-2]
77. Dickinson J.E. Misoprostol for second-trimester pregnancy termination in women with a prior cesarean delivery. Obstet Gynecol 105 (2005) 352-356 [Evidence Grade: II-2]
78. Daponte A., Nzewenga G., Dimopoulos K.D., and Guidozzi F. The use of vaginal misoprostol for second-trimester pregnancy termination in women with previous single cesarean section. Contraception 74 (2006) 324-327 [Evidence Grade: II-3]
79. Bhattacharjee N., Ganguly R.P., and Saha S.P. Misoprostol for termination of mid-trimester post-caesarean pregnancy. Aust N Z J Obstet Gynaecol 47 (2007) 23-25 [Evidence Grade: II-2]
80. Mazouni C., Provensal M., Porcu G., Guidicelli B., Heckenroth H., Gamerre M., et al. Termination of pregnancy in patients with previous cesarean section. Contraception 73 (2006) 244-248 [Evidence Grade: II-2]
81. Berghahn L., Christensen D., and Droste S. Uterine rupture during second-trimester abortion associated with misoprostol. Obstet Gynecol 98 (2001) 976-977 [Evidence Grade: III]
82. Halperin R., Zimmerman A., Langer R., Bukovsky I., and Schneider D. Laminaria dilatation and evacuation for pregnancies with mid-trimester premature rupture of membranes: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol 100 (2002) 181-184 [Evidence Grade: II-2]
83. Thomas A.G., Alvarez M., Friedman Jr. F., Brodman M.L., Kim J., and Lockwood C. The effect of placenta previa on blood loss in second-trimester pregnancy termination. Obstet Gynecol 84 (1994) 58-60 [Evidence Grade: II-2]
84. Halperin R., Vaknin Z., Langer R., Bukovsky I., and Schneider D. Late midtrimester pregnancy termination in the presence of placenta previa. J Reprod Med 48 (2003) 175-178 [Evidence Grade: II-2]